Evonik Industries (EVK) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
3 Jun, 2026Opening remarks and agenda
The meeting was opened virtually in accordance with company articles and German law, with all formalities and notification requirements confirmed as met.
Shareholders were informed about their rights to speak, ask questions, and submit motions via the online service, with technical instructions provided.
Voting procedures, including postal and proxy voting, were explained, with flexibility to change votes during the meeting.
Board and executive committee updates
Two new employee representatives, Melanie Knappe and Frank Münch, joined the Supervisory Board, succeeding outgoing members.
Michael Rauch was appointed CFO, succeeding Maike Schuh, bringing extensive industry and capital markets experience.
The contract of the Chairman of the Executive Board, Mr. Kullmann, was extended until 2030, signaling stability.
Financial performance review
The group faced significant challenges in 2025 due to global economic and geopolitical pressures, especially erratic U.S. tariff policy.
Adjusted EBITDA for 2025 was nearly EUR 1.9 billion, with free cash flow close to EUR 700 million.
Share price volatility was noted, with a 20% drop in 2025 but a 30% rise since early 2026 following strategic decisions.
Q1 2026 EBITDA reached EUR 475 million, with Q2 expected to improve further.
Latest events from Evonik Industries
- Q2 2026 adjusted EBITDA up 24% to €630M; 2026 guidance raised amid strong segment gains.EVK
Q2 20264 Aug 2026 - Q2 2026 EBITDA up 24%, FY outlook raised, and new dividend policy introduced.EVK
Company presentation4 Aug 2026 - Q3 adjusted EBITDA up 19%, margin at 15%, and 2024 outlook confirmed amid uncertainty.EVK
Q3 20249 Jul 2026 - Despite a tough year, stable dividends and strategic transformation were maintained.EVK
AGM 20248 Jul 2026 - Targeting €1bn EBITDA growth and 11% ROCE by 2027 through innovation, optimization, and sustainability.EVK
CMD 20258 Jul 2026 - Integrated innovation and sustainability drive growth in biosolutions, hydrogen, and recycling.EVK
Investor update10 Jun 2026 - Q1 2026 EBITDA exceeded forecasts, but sales and net income fell; outlook remains stable.EVK
Q1 202610 May 2026 - Q1 2026 outperformed expectations, with robust cash flow and FY guidance reaffirmed.EVK
Company presentation8 May 2026 - Achieved FY 2025 guidance with robust cash flow and a new dividend policy for future flexibility.EVK
Investor presentation4 Mar 2026